Publication:
Systematic Review of International Population Studies With Cardiac Magnetic Resonance and Genomics Research Data ("Imagenomics").

dc.contributor.authorHesse, Kerrick
dc.contributor.authorAung, Nay
dc.contributor.authorPetersen, Steffen E
dc.contributor.authorSiripanthong, Bhurint
dc.contributor.authorCaptur, Gabriella
dc.contributor.authorYeo, Khung Keong
dc.contributor.authorFriedrich, Matthias G
dc.contributor.authorJaddoe, Vincent W V
dc.contributor.authorDörr, Marcus
dc.contributor.authorPischon, Tobias
dc.contributor.authorBluemke, David A
dc.contributor.authorIbáñez, Borja
dc.contributor.authorFuster, Valentin
dc.contributor.authorChahal, C Anwar A
dc.contributor.authorKhanji, Mohammed Y
dc.date.accessioned2026-04-27T09:44:32Z
dc.date.available2026-04-27T09:44:32Z
dc.date.issued2026-02-20
dc.description.abstractEpidemiological population studies may include cardiac magnetic resonance (CMR)-derived phenotyping and large-scale genotyping, providing unprecedented level of detail to investigate novel gene-lifestyle-disease interactions. The systematic review presents high-level summaries and critically appraises contemporary challenges and biobank opportunities. The authors identified 17 relevant biobanks by searching "CMR," "genome" and "population study" on MEDLINE, EMBASE, and Web of Science 2025. Collectively, studies recruited ∼1 million participants with stored blood samples for extensive genomic analyses, of whom >180,000 have or will undergo CMR. Use of expansive personal data must safeguard participant confidentiality, encourage technological standardization, and champion inclusivity and sustainability. Application of genotypic and imaging-derived phenotypic information will be readily translatable to clinical practice through investigation of, among others, new therapeutic targets and highly sensitive and specific biomarkers. Imaging biobanks are accessible to researchers by application. This systematic review should inspire greater use and cross-collaboration and facilitate powerful discoveries in more heterogeneous population samples.
dc.description.peerreviewed
dc.description.tableofcontentsDr Hesse has been supported by a British Heart Foundation Clinical Research Training Fellowship number FS/CRTF/23/24428. Dr Aung has received support from Medical Research Council for his Clinician Scientist Fellowship (MR/X020924/1). Dr Petersen has received grants from the European Union’s Horizon 2020 research and innovation program under grant agreement number 825903 (euCanSHare project), the British Heart Foundation for funding the manual analysis to create a cardiac magnetic resonance reference standard for the UK Biobank imaging resource in 5000 CMR scans (www.bhf.org.uk; PG/14/89/31194, “SmartHeart” EPSRC program grant (www.nihr.ac.uk; EP/P001009/1); and has received consulting fees from Cardiovascular Imaging Inc, Calgary, Alberta, Canada. Dr Captur has received grants from the British Heart Foundation (BHF, MyoFit46 Special Programme Grant SP/20/2/34841), the BHF Accelerator Award (AA/18/6/34223), the NIHR Invention for Innovation FAST grant scheme (iFAST NIHR205960), and the NIHR UCL Hospitals Biomedical Research Centre (BRC). Dr Yeo has received grant support for the SingHEART study conducted at the National Heart Centre Singapore by the Lee Foundation and in memory of Mr Henry H.L. Kwee, SingHealth and Duke-NUS Institute of Precision Medicine (PRISM); and has received a center grant awarded to the National Heart Centre Singapore from the National Medical Research Council, Ministry of Health, Singapore (CGAug16M006 and NMRC/CG1/003/2021-NHCS). Dr Friedrich is shareholder of Area19 Medical Inc, Montreal, Quebec, Canada and Circle Cardiovascular Imaging Inc, Calgary, Alberta, Canada. Dr Pischon has received grants from NAKO by the Federal Ministry of Education and Research (BMBF) [project funding reference numbers: 01ER1301A/B/C, 01ER1511D, 01ER1801A/ B/C/D and 01ER2301A/B/C], federal states of Germany and the Helmholtz Association, and the participating universities and the institutes of the Leibniz Association. Dr Bluemke has received consulting fees from GE HealthCare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
dc.identifier.citationJACC Cardiovasc Imaging. 2026 Feb 20:S1936-878X(26)00050-1.
dc.identifier.journalJACC. Cardiovascular Imaging
dc.identifier.pubmedID41758108
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27445
dc.language.isoeng
dc.publisherElsevier
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1016/j.jcmg.2026.01.007
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovascular
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectcardiovascular magnetic resonance
dc.subjectgenomics
dc.subjectpopulation study
dc.titleSystematic Review of International Population Studies With Cardiac Magnetic Resonance and Genomics Research Data ("Imagenomics").
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Systematic Review of International Population_JACC Cardiovasc Imaging_2026.pdf
Size:
3.48 MB
Format:
Adobe Portable Document Format